Dietary Supplements

Browse Dietary Supplements Content

Product Safety & Integrity

Consumer Healthcare Products Association members agree voluntarily to the following provisions pertaining to pyrrolizidine alkaloids.

Transparency

To address the growing need for more information on dietary supplements available in the market, the Office of Dietary Supplements at the National Institutes of Health has developed the Dietary Supplement Label Database. This valuable resource compiles comprehensive information obtained from the labels of dietary supplement products sold in the United States.

Product Safety & Integrity

CHPA members agree voluntarily to market products containing kava with the following dosage and labeling.

CHPA's member-only weekly report from our State & Local Government Affairs team, reporting on recent legislative activity around the country affecting our industry.

Informed Consumer Decision Making

Members of the Consumer Healthcare Products Association who market dietary supplements containing St. John's wort initiated a voluntary labeling program on April 2, 2000.

Learn more about the issues CHPA addresses in the OTC medicine, dietary supplement, and consumer medical device industries.

Industry Self-Regulation for Dietary Supplements

This document serves as a voluntary guideline to assist manufacturers of dietary supplements with compliance with the dietary supplement current good manufacturing practice (cGMP) requirements of the US FDA 21 CFR §111.

CHPA opposes state and local government attempts to restrict the use of FDA-approved color additives as doing so is vital for maintaining a cohesive regulatory framework.

Learn about CHPA's current slate of federal legislative priorities including OTC regulatory reform, dietary supplement regulation modernization, supply chain and product integrity, and more.

Filter Results